From Curiosity to Impact: A Leadership Conversation with Dr. Christian Roesky

Christian Roesky is the CEO of Novaliq, a biopharmaceutical company pioneering water-free ophthalmic therapies. With more than three decades of experience in the pharmaceutical industry, his career has spanned senior leadership roles across global pharmaceutical organizations before transitioning into the biotech world. Under his leadership, Novaliq has evolved from a promising technology platform into a company with multiple approved products and a growing international footprint. His career reflects a unique combination of scientific innovation, entrepreneurial thinking, and a strong focus on execution.

In conversation with Elyas Bozan, Managing Director DACH and Global Practice Head Life Sciences at Morgan Philips Group, Christian Roesky shares insights on his journey to becoming a CEO, the role of mentors in shaping leadership, the challenge of commercializing breakthrough innovation, and how his definition of success has evolved over the course of his career.

Looking back, what has helped you become a CEO?

I’ve always been curious, analytical, and purpose-driven. Over time, I learned that leadership, emotional intelligence, change management, and financial acumen are just as important as technical expertise.

During your years in big pharma, what shaped your development the most?

Helping build a European headquarters from scratch taught me how to create structure and drive growth. At the same time, early exposure to senior executives gave me invaluable insight into strategy and leadership.

How important were mentors and role models in your journey?

Extremely important. Looking back, many leaders were intentionally preparing me for bigger responsibilities by challenging me, stretching me, and creating opportunities to grow.

You moved into senior leadership roles relatively early. How did you manage stakeholders at a young age?

I was never afraid of disagreement or losing status. I focused on strong arguments, trust, and respect. I also learned that alignment often happens before the meeting, making relationships critical.

What convinced you to believe in water-free eye therapies, and how did you help scale the innovation?

Initially, I was sceptical. But once I understood the science, I saw its potential. My role was to turn innovation into execution by focusing the company on a few strategic priorities, several of which have since achieved regulatory approval.

What does entrepreneurial courage mean to you?

It means embracing uncertainty. Success comes from recognizing opportunities, developing a clear plan, and executing with discipline—even when the outcome isn’t guaranteed.

What does success mean to you today?

Earlier in my career, success was about winning and achieving results. Today, it’s about helping others grow, giving back, and creating opportunities for the next generation of leaders. That’s the legacy I care most about.